Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effects of zuclomiphene in combination with triparanol and AY-9944 on developing rat CNS morphology and biochemistry

  • 22 Accesses

  • 4 Citations

Summary

Developing rats were injected intraperitoneally twice weekly with a combination of three hypocholesterolemic agents: Zuclomiphene (formerly calledtrans-clomiphene; dosage, 30 mg/kg body weight), Triparanol (30 mg/kg body weight) and AY-9944 (3 mg/kg body weight). Treatment was initiated at 4 days of age. Biochemical and electron microscopic examination was conducted on animals sacrificed at 20 days of age. Cytoplasmic inclusion bodies were not seen in the CNS. Isolated edematous changes were seen in myelinated axons. Analysis of the sterol content of the brain and spinal cords of drugtreated animals indicated the presence of abnormal concentrations of five sterols, desmosterol, 5α-cholesta-7,24-dien-3β-ol, zymosterol (5α-cholesta-8,24-dien-3β-ol), 7-dehydrocholesterol (cholesta-5,7-dien-3β-ol) and 7-dehydrodesmosterol (cholesta-5,7,24-trien-3β-ol). Zymosterol and 5α-cholesta-7,24-dien-3β-ol were minor constituents (5–7% and 1–1.5% of total sterol, respectively). The 7-dehydrosterols represented approximately one-half (44–52%) of the total CNS sterol.

This is a preview of subscription content, log in to check access.

References

  1. Folch, J., Lees, M., Sloane-Stanley G. H.: A simple method for the isolation and purification of total lipids from animal tissues. J. biol. Chem.226, 497–509 (1957)

  2. Gray, J. E., Purmalis, A., Purmalis, B., Mathews, J.: Ultrastructural studies of the hepatic changes brought about by clindamycin and erythromycin in animals. Toxicol. appl. Pharmacol.19, 217–233 (1971)

  3. Hruban, Z., Slesers, A., Hopkins, E.: Drug-induced and naturally occurring myeloid bodies. Lab. Invest.27, 62–70 (1972)

  4. Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O.: Drug-induced phospholipidosis. Crit. Rev. Toxicol.4, 185–218 (1975)

  5. Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O.: Drug-induced phospholipidosis. Germ. Med.3, 128–135 (1973)

  6. Ramsey, R. B., Aexel, R. T., Nicholas, H. J.: Formation of methyl sterols in brain cholesterol biosynthesis: Sterol formation in vitro and in vivo in adult rat brain. J. biol. Chem.246, 6393–6400 (1971)

  7. Ramsey, R. B., Aexel, R. T., Jones, J. P., Nicholas, H. J.: Formation of methyl sterols in brain cholesterol biosynthesis: Sterol formation in vitro in actively myelinating rat brain. J. biol. Chem.247, 3471–3475 (1972)

  8. Ramsey, R. B., Fischer V. W., Nicholas, H. J., Fredericks, M.: Inhibition of CNS cholesterol biosynthesis bytrans-clomiphene and AY-9944. Soc. Neurosci.1, 328 (1975)

  9. Ramsey, R. B., Fischer, V. W.: Effect of zuclomiphene, AY-9944 and Triparanol on CNS cholesterol formation. Soc. Neurosci.2, 611 (1976b)

  10. Ramsey, R. B., Fischer, V. W.: Effect oftrans-clomiphene in combination with AY-9944 on rat CNS morphology and biochemistry. Acta neuropath. (Berl.)36, 91–96 (1976c)

  11. Ramsey, R. B., Fredercks, M., Fischer, V. W.: Effect oftrans-clomiphene and AY-9944 on CNS cholesterol formation. Trans. Amer. Soc. Neurochem.7, 131 (1976a)

  12. Schmien, R., Seiler, K.-U., Wassermann, O.: Drug-induced phospholipidosis I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment. Naunyn-Schmiedeberg's Arch. Pharmacol.283, 331–334 (1974)

  13. Seiler, K.-U., Wassermann, O.: Drug-induced phospholipidosis II. Alterations in the phospholipid pattern of organs from mice, rats and guinea pigs after chronic treatment with chlorphentermine. Naunyn-Schmiedeberg's Arch. Pharmacol.288, 261–268 (1975)

  14. Suzuki, K., Zagoren, J. D., Chen, S. M., Suzuki, K.: Effects of Triparanol and 20,25-diazacholesterol in CNS of rat: Morphological and biochemical studies. Acta neuropath. (Berl.)29, 141–156 (1974)

  15. Suzuki, K., Zagoren, J. D., Gonatas, J., Suzuki, K.: Ultrastructural study of neuronal cytoplasmic inclusions produced by hypocholesterolemic drug. AY-9944. Acta neuropath. (Berl.)26, 185–197 (1973)

  16. Thys, O., Hildebrand, J., Gerin, Y., Jacques, P. J.: Alterations of rat liver lysosomes and smooth endoplasmic reticulum induced by the diazafluoranthen derivative AC-35791. Morphologic and biochemical lesions. Lab. Invest.28, 70–82 (1973)

  17. Yates, R. D., Arai, K., Rappaport, D. A.: Fine structure and chemical composition of opaque cytoplasmic bodies of triparanol treated Syrian hamsters. Exp. Cell Res.47, 459–478 (1967)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ramsey, R.B., Fischer, V.W. Effects of zuclomiphene in combination with triparanol and AY-9944 on developing rat CNS morphology and biochemistry. Acta Neuropathol 39, 97–100 (1977). https://doi.org/10.1007/BF00690391

Download citation

Key words

  • Brain
  • Spinal cord
  • Hypocholesterolemic agents
  • Cholesterol
  • Desmosterol
  • Lipids
  • Cytoplasmic inclusion bodies
  • Zuclomiphene
  • AY-9944
  • Triparanol